ALK-Abello A/S
CSE:ALK B

Watchlist Manager

ALK-Abello A/S

CSE:ALK B

Watchlist

Dividends

Price: 157.8 DKK -2.17%

Market Cap: 34.9B DKK

Have any thoughts about
ALK-Abello A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 157.8 DKK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ALK B Alert

ALK-Abello A/S

157.8

-3.5 (-2.17%)

52 Week Range	100 182.6
Price Target

We'll email you a reminder when the closing price reaches DKK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

ALK-Abello A/S

What unique competitive advantages
does ALK-Abello A/S hold over its rivals?

What risks and challenges
does ALK-Abello A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of ALK-Abello A/S.

What unique competitive advantages
does ALK-Abello A/S hold over its rivals?

What risks and challenges
does ALK-Abello A/S face in the near future?

Summarize the latest earnings call
of ALK-Abello A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ALK-Abello A/S.

Provide P/S
for ALK-Abello A/S.

Provide P/E
for ALK-Abello A/S.

Provide P/OCF
for ALK-Abello A/S.

Provide P/FCFE
for ALK-Abello A/S.

Provide P/B
for ALK-Abello A/S.

Provide EV/S
for ALK-Abello A/S.

Provide EV/GP
for ALK-Abello A/S.

Provide EV/EBITDA
for ALK-Abello A/S.

Provide EV/EBIT
for ALK-Abello A/S.

Provide EV/OCF
for ALK-Abello A/S.

Provide EV/FCFF
for ALK-Abello A/S.

Provide EV/IC
for ALK-Abello A/S.

Show me price targets
for ALK-Abello A/S made by professional analysts.

What are the Revenue projections
for ALK-Abello A/S?

How accurate were the past Revenue estimates
for ALK-Abello A/S?

What are the Net Income projections
for ALK-Abello A/S?

How accurate were the past Net Income estimates
for ALK-Abello A/S?

What are the EPS projections
for ALK-Abello A/S?

How accurate were the past EPS estimates
for ALK-Abello A/S?

What are the EBIT projections
for ALK-Abello A/S?

How accurate were the past EBIT estimates
for ALK-Abello A/S?

Compare the revenue forecasts
for ALK-Abello A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ALK-Abello A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ALK-Abello A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of ALK-Abello A/S compared to its peers.

Compare the P/E ratios
of ALK-Abello A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing ALK-Abello A/S with its peers.

Analyze the financial leverage
of ALK-Abello A/S compared to its main competitors.

Show all profitability ratios
for ALK-Abello A/S.

Provide ROE
for ALK-Abello A/S.

Provide ROA
for ALK-Abello A/S.

Provide ROIC
for ALK-Abello A/S.

Provide ROCE
for ALK-Abello A/S.

Provide Gross Margin
for ALK-Abello A/S.

Provide Operating Margin
for ALK-Abello A/S.

Provide Net Margin
for ALK-Abello A/S.

Provide FCF Margin
for ALK-Abello A/S.

Show all solvency ratios
for ALK-Abello A/S.

Provide D/E Ratio
for ALK-Abello A/S.

Provide D/A Ratio
for ALK-Abello A/S.

Provide Interest Coverage Ratio
for ALK-Abello A/S.

Provide Altman Z-Score Ratio
for ALK-Abello A/S.

Provide Quick Ratio
for ALK-Abello A/S.

Provide Current Ratio
for ALK-Abello A/S.

Provide Cash Ratio
for ALK-Abello A/S.

What is the historical Revenue growth
over the last 5 years for ALK-Abello A/S?

What is the historical Net Income growth
over the last 5 years for ALK-Abello A/S?

What is the current Free Cash Flow
of ALK-Abello A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for ALK-Abello A/S.

EV/EBITDA
Enterprise Value to EBITDA

25.9

Current

31.6

Median

13.5

Industry

Lower than median

Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

25.9

Enterprise Value

35.6B DKK

EBITDA

1.3B DKK

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
DK		ALK-Abello A/S CSE:ALK B	34.8B DKK	25.9
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-5 459 134.4
US		Eli Lilly and Co NYSE:LLY	729.3B USD	46.9
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	3 846.3
DK		Novo Nordisk A/S CSE:NOVO B	2.9T DKK	20.9
US		Johnson & Johnson NYSE:JNJ	347.8B USD	11.5
US		Merck & Co Inc NYSE:MRK	248.3B USD	10.3
CH		Roche Holding AG SIX:ROG	197B CHF	9.7
UK		AstraZeneca PLC LSE:AZN	160.1B GBP	169.3
CH		Novartis AG SIX:NOVN	169.8B CHF	9.4
US		Pfizer Inc NYSE:PFE	149.4B USD	10.5

				EBITDA Growth	EV/EBITDA to Growth
DK		ALK-Abello A/S CSE:ALK B	Average EV/EBITDA: 416.1 25.9	138%	0.2
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -5 459 134.4	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	46.9	195%	0.2
UK		Dechra Pharmaceuticals PLC LSE:DPH	3 846.3	151%	25.5
DK		Novo Nordisk A/S CSE:NOVO B	20.9	84%	0.3
US		Johnson & Johnson NYSE:JNJ	11.5	14%	0.8
US		Merck & Co Inc NYSE:MRK	10.3	331%	0
CH		Roche Holding AG SIX:ROG	9.7	23%	0.4
UK		AstraZeneca PLC LSE:AZN	169.3	64%	2.6
CH		Novartis AG SIX:NOVN	9.4	8%	1.2
US		Pfizer Inc NYSE:PFE	10.5	31%	0.3

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

24.2

2-Years Forward

EV/EBITDA

18.5

3-Years Forward

EV/EBITDA

16.4

	Franklin Covey Co NYSE:FC	36.41 USD -1.03%
	Mohawk Industries Inc NYSE:MHK	119.16 USD 2%
	Ardmore Shipping Corp NYSE:ASC	11.31 USD 0.18%
	ASGN Inc NYSE:ASGN	83.87 USD -0.97%
	Skyworks Solutions Inc NASDAQ:SWKS	88.75 USD 0.56%
	Weatherford International PLC NASDAQ:WFRD	67.1 USD -2.13%

	Johnson & Johnson NYSE:JNJ	144.47 USD 0.62%
	Bank of America Corp NYSE:BAC	44.17 USD 1.82%
	Mastercard Inc NYSE:MA	528.03 USD 0.91%
	Salesforce Inc NYSE:CRM	343.65 USD 2.21%
	Abbvie Inc NYSE:ABBV	175.58 USD 2.37%
	Home Depot Inc NYSE:HD	392.6 USD 1.97%

	Arista Networks Inc NYSE:ANET	112.81 USD 3.43%
	Visa Inc NYSE:V	317.71 USD 0.9%
	Texas Pacific Land Corp NYSE:TPL	1 133.12 USD 3.36%
	KLA Corp NASDAQ:KLAC	629.37 USD 1.16%
	Manhattan Associates Inc NASDAQ:MANH	280.26 USD -0.81%
	Pinduoduo Inc NASDAQ:PDD	99.51 USD -1.48%

	Salesforce Inc NYSE:CRM	343.65 USD 2.21%
	Accenture PLC NYSE:ACN	366.37 USD -1.56%
	ServiceNow Inc NYSE:NOW	1 091.25 USD 1.52%
	EOG Resources Inc NYSE:EOG	119.04 USD 0.69%
	Copart Inc NASDAQ:CPRT	58.22 USD -0.39%
	Applied Materials Inc NASDAQ:AMAT	163.59 USD 1.33%

ALK-Abello A/S
CSE:ALK B

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

ALK-Abello A/S CSE:ALK B

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

ALK-Abello A/S
CSE:ALK B

EV/EBITDA
Enterprise Value to EBITDA